Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15377584.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Neuroleptic malignant syndrome is a rare complication when using neuroleptic drugs. We report the case of a patient with severe Parkinson's disease who developed neuroleptic malignant syndrome after withdrawal of his antiParkinsonian medication for elective coronary artery bypass grafting. Sodium dantrolene may be a therapeutic option in severe cases.
Medical subject headings
- Antiparkinson Agents
- Neuroleptic Malignant Syndrome
- Postoperative Complications
- Substance Withdrawal Syndrome